Chargement en cours...

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases

INTRODUCTION: Rituximab (RTX) is a monoclonal antibody targeting CD20, a transmembrane protein expressed on B cells, causing B cell depletion. RTX has shown great efficacy in studies of pemphigus vulgaris, but data of pemphigoid diseases are limited. OBJECTIVE: To assess the effectiveness and safety...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Lamberts, Aniek, Euverman, H. Ilona, Terra, Jorrit B., Jonkman, Marcel F., Horváth, Barbara
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5827539/
https://ncbi.nlm.nih.gov/pubmed/29520266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00248
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!